CN111417381B - Oral scale remover, oral scale formation inhibitor, and oral composition - Google Patents
Oral scale remover, oral scale formation inhibitor, and oral composition Download PDFInfo
- Publication number
- CN111417381B CN111417381B CN201880076794.6A CN201880076794A CN111417381B CN 111417381 B CN111417381 B CN 111417381B CN 201880076794 A CN201880076794 A CN 201880076794A CN 111417381 B CN111417381 B CN 111417381B
- Authority
- CN
- China
- Prior art keywords
- acid
- oral
- component
- oral cavity
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 99
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 81
- 239000003112 inhibitor Substances 0.000 title claims abstract description 22
- -1 alginic acid ester Chemical class 0.000 claims abstract description 48
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 46
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 45
- 229920000615 alginic acid Polymers 0.000 claims abstract description 45
- 229920000058 polyacrylate Polymers 0.000 claims abstract description 43
- 239000002689 soil Substances 0.000 claims abstract description 38
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 33
- 150000003839 salts Chemical class 0.000 claims abstract description 31
- 239000000783 alginic acid Substances 0.000 claims abstract description 28
- 229960001126 alginic acid Drugs 0.000 claims abstract description 28
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229940072056 alginate Drugs 0.000 claims abstract description 15
- 150000004781 alginic acids Chemical class 0.000 claims abstract description 14
- 239000007864 aqueous solution Substances 0.000 claims abstract description 14
- 239000002738 chelating agent Substances 0.000 claims abstract description 14
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract description 13
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims abstract description 12
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims abstract description 12
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims abstract description 12
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000467 phytic acid Substances 0.000 claims abstract description 12
- 229940068041 phytic acid Drugs 0.000 claims abstract description 12
- 235000002949 phytic acid Nutrition 0.000 claims abstract description 12
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract description 11
- 239000001630 malic acid Substances 0.000 claims abstract description 11
- 235000011090 malic acid Nutrition 0.000 claims abstract description 11
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 8
- 229960001484 edetic acid Drugs 0.000 claims abstract description 8
- 239000000551 dentifrice Substances 0.000 claims description 22
- 229960004106 citric acid Drugs 0.000 claims description 10
- 229940099690 malic acid Drugs 0.000 claims description 10
- 229960004838 phosphoric acid Drugs 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 110
- 210000000214 mouth Anatomy 0.000 abstract description 68
- 238000004181 pedogenesis Methods 0.000 abstract description 11
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract description 9
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract description 8
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 abstract description 7
- 238000000034 method Methods 0.000 description 39
- 238000002156 mixing Methods 0.000 description 34
- 230000005764 inhibitory process Effects 0.000 description 25
- 239000000796 flavoring agent Substances 0.000 description 16
- 235000019634 flavors Nutrition 0.000 description 15
- 229920002125 Sokalan® Polymers 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 235000019645 odor Nutrition 0.000 description 13
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 12
- 230000007794 irritation Effects 0.000 description 12
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 12
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 239000004584 polyacrylic acid Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 10
- 125000004432 carbon atom Chemical group C* 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 235000015424 sodium Nutrition 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 239000011230 binding agent Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 159000000000 sodium salts Chemical class 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- 125000002252 acyl group Chemical group 0.000 description 6
- 229960003237 betaine Drugs 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 239000002736 nonionic surfactant Substances 0.000 description 6
- 238000005498 polishing Methods 0.000 description 6
- 239000003082 abrasive agent Substances 0.000 description 5
- 239000003945 anionic surfactant Substances 0.000 description 5
- 239000010408 film Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 150000008051 alkyl sulfates Chemical class 0.000 description 4
- 230000001680 brushing effect Effects 0.000 description 4
- 239000001506 calcium phosphate Substances 0.000 description 4
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 4
- 210000002200 mouth mucosa Anatomy 0.000 description 4
- 235000019477 peppermint oil Nutrition 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 235000010413 sodium alginate Nutrition 0.000 description 4
- 239000000661 sodium alginate Substances 0.000 description 4
- 229940005550 sodium alginate Drugs 0.000 description 4
- 235000019832 sodium triphosphate Nutrition 0.000 description 4
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 235000005206 Hibiscus Nutrition 0.000 description 3
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 3
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 125000004442 acylamino group Chemical group 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- ZSBWUNDRDHVNJL-UHFFFAOYSA-N 2-Methyl-2-cyclopenten-1-one Chemical compound CC1=CCCC1=O ZSBWUNDRDHVNJL-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-UHFFFAOYSA-N 3,7-dimethylocta-1,6-dien-3-yl acetate Chemical compound CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- 239000000120 Artificial Saliva Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000005973 Carvone Substances 0.000 description 2
- 235000014112 Cassia mimosoides Nutrition 0.000 description 2
- 244000302899 Cassia mimosoides Species 0.000 description 2
- 108010001682 Dextranase Proteins 0.000 description 2
- 241000511976 Hoya Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000005807 Nelumbo Nutrition 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 208000025157 Oral disease Diseases 0.000 description 2
- 235000019502 Orange oil Nutrition 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- YYRMJZQKEFZXMX-UHFFFAOYSA-N calcium;phosphoric acid Chemical compound [Ca+2].OP(O)(O)=O.OP(O)(O)=O YYRMJZQKEFZXMX-UHFFFAOYSA-N 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000008369 fruit flavor Substances 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 208000030194 mouth disease Diseases 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 238000000569 multi-angle light scattering Methods 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- 239000010661 oregano oil Substances 0.000 description 2
- 229940111617 oregano oil Drugs 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 2
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 2
- 238000005488 sandblasting Methods 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 235000019983 sodium metaphosphate Nutrition 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000002426 superphosphate Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- IAEGWXHKWJGQAZ-UHFFFAOYSA-N trimethylpyrazine Chemical compound CC1=CN=C(C)C(C)=N1 IAEGWXHKWJGQAZ-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- NZGWDASTMWDZIW-MRVPVSSYSA-N (+)-pulegone Chemical compound C[C@@H]1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-MRVPVSSYSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- JHEPBQHNVNUAFL-AATRIKPKSA-N (e)-hex-1-en-1-ol Chemical compound CCCC\C=C\O JHEPBQHNVNUAFL-AATRIKPKSA-N 0.000 description 1
- YYMCVDNIIFNDJK-XFQWXJFMSA-N (z)-1-(3-fluorophenyl)-n-[(z)-(3-fluorophenyl)methylideneamino]methanimine Chemical compound FC1=CC=CC(\C=N/N=C\C=2C=C(F)C=CC=2)=C1 YYMCVDNIIFNDJK-XFQWXJFMSA-N 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- MVOSYKNQRRHGKX-UHFFFAOYSA-N 11-Undecanolactone Chemical compound O=C1CCCCCCCCCCO1 MVOSYKNQRRHGKX-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QBCRICHFTLCUHE-UHFFFAOYSA-N 2-(dimethylamino)-3-oxotetradecanoic acid Chemical compound CCCCCCCCCCCC(=O)C(N(C)C)C(O)=O QBCRICHFTLCUHE-UHFFFAOYSA-N 0.000 description 1
- MDVYIGJINBYKOM-UHFFFAOYSA-N 3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]-1,2-propanediol Chemical compound CC(C)C1CCC(C)CC1OCC(O)CO MDVYIGJINBYKOM-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- JIDDFPFGMDDOLO-UHFFFAOYSA-N 5-fluoro-1-(1-oxothiolan-2-yl)pyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(F)=CN1C1S(=O)CCC1 JIDDFPFGMDDOLO-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 208000035154 Hyperesthesia Diseases 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- LQKRYVGRPXFFAV-UHFFFAOYSA-N Phenylmethylglycidic ester Chemical compound CCOC(=O)C1OC1(C)C1=CC=CC=C1 LQKRYVGRPXFFAV-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- NZGWDASTMWDZIW-UHFFFAOYSA-N Pulegone Natural products CC1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- APTGPWJUOYMUCE-UHFFFAOYSA-N S-Ethyl thioacetate Chemical compound CCSC(C)=O APTGPWJUOYMUCE-UHFFFAOYSA-N 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010044029 Tooth deposit Diseases 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- NNCOOIBIVIODKO-UHFFFAOYSA-N aluminum;hypochlorous acid Chemical compound [Al].ClO NNCOOIBIVIODKO-UHFFFAOYSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000006103 coloring component Substances 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229910002026 crystalline silica Inorganic materials 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- IPGANOYOHAODGA-UHFFFAOYSA-N dilithium;dimagnesium;dioxido(oxo)silane Chemical compound [Li+].[Li+].[Mg+2].[Mg+2].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O IPGANOYOHAODGA-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- FXNRKXSSLJKNGH-UHFFFAOYSA-L dipotassium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [K+].[K+].[O-]P([O-])(F)=O FXNRKXSSLJKNGH-UHFFFAOYSA-L 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- 229940091249 fluoride supplement Drugs 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229940070800 myristoyl glutamate Drugs 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 239000000668 oral spray Substances 0.000 description 1
- 229940041678 oral spray Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229930007459 p-menth-8-en-3-one Natural products 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000001920 pimenta acris kostel leaf oil terpeneless Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940051841 polyoxyethylene ether Drugs 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- URLJMZWTXZTZRR-UHFFFAOYSA-N sodium myristyl sulfate Chemical compound CCCCCCCCCCCCCCOS(O)(=O)=O URLJMZWTXZTZRR-UHFFFAOYSA-N 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- 229960003339 sodium phosphate Drugs 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/51—Chelating agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Provided are an oral cavity dirt remover with excellent effect of removing oral cavity dirt, an oral cavity dirt formation inhibitor with excellent effect of inhibiting oral cavity dirt formation, and an oral cavity composition containing the same. An oral cavity soil remover comprising (a) a polyacrylate salt having a weight average molecular weight of 1,000 to 20,000; an oral cavity soil remover comprising the component (a) and (b) a chelating agent selected from 1 or more of condensed phosphoric acid, phytic acid, edetic acid, citric acid, malic acid, succinic acid, dicarboxylic acid and salts thereof, wherein the pH of the 1 mass% aqueous solution at 25 ℃ is 1 to 11; and an oral composition comprising the above components (a) and (b). An inhibitor for oral cavity soil formation comprising the component (a), an inhibitor for oral cavity soil formation comprising the component (a) and at least 1 alginic acid derivative selected from the group consisting of an alginate and an alginic acid ester, and an oral cavity composition comprising the components (a) and (c).
Description
Technical Field
The present invention relates to an oral scale remover, an oral scale formation inhibitor, and an oral composition containing the same, which are effective in inhibiting the adhesion of scale to teeth and are useful for whitening teeth.
Background
The stains, which are one type of stains for teeth, are formed by a film containing a coloring component contained in saliva, foods, beverages, and foods, and hobbies, which adhere to the tooth surface, causing a coloring reaction, and being laminated and deposited with time and fixed to the tooth surface, and become strong stains. As a means for suppressing the adhesion of dirt to solve this problem, a method of removing dirt and a method of suppressing the formation of dirt can be considered.
Conventionally, in the means for removing colored stains, polishing removal by physical action of a polishing agent mixed in a composition is a common means, but there is a limit in that problems such as abrasion of oral mucosa and dentin at a suitable site may occur due to an increase in the polishing agent amount. Further, it is also known to impart a soil removal effect by using a condensed phosphate such as sodium polyphosphate, however, there are cases where such: if the amount of the condensed phosphate to be mixed is not relatively large, the effect cannot be exhibited, and further, as the amount to be mixed increases, there is a problem that the oral mucosa becomes more irritating.
Patent document 1 (WO 2016/194645) proposes: by combining condensed phosphate and fatty acid or fatty acid ester having a specific branched structure, a technique of removing dirt by chemical action while relaxing oral mucosa irritation is proposed in patent document 2 (japanese unexamined patent publication No. 9-175966), and a technique of removing dirt stains on the tooth surface by chemical action while mixing water-soluble pyrophosphate and polyphosphate is proposed, but there is room for improvement in the removal effect.
In addition, a technique for preventing the formation of dirt in advance has been attracting attention, and establishment of a technique for suppressing the formation of dirt has been desired.
As a method for suppressing the formation of dirt, patent documents 3 to 5 (japanese patent application laid-open publication No. 2003-81797, japanese patent application laid-open publication No. 2013-142061, japanese patent application laid-open publication No. 2015-174830) propose a method using various surfactants, but there are cases in which: if the amount of the surfactant to be mixed is not relatively large, the effect cannot be exhibited, and the odor derived from the surfactant is generated.
On the other hand, patent document 6 (japanese patent application laid-open No. 2000-247851) proposes: as a coloring-inhibiting coating agent for inhibiting the coloring of teeth caused by accumulation of stains, a technique of using polyacrylic acid or the like having a molecular weight of 2 ten thousand or more is proposed in patent document 7 (japanese patent publication No. 7-29907): polyacrylic acid polymers or polyacrylic acid copolymers having a weight average molecular weight of about 3,500 to 7,500 are mixed in an oral composition in an amount of about 2.5% or more as an anticalculus agent.
Prior art literature
Patent literature
WO2016/194645 [ patent document 1 ]
Japanese patent application laid-open No. 9-175966
Japanese patent application laid-open No. 2003-81797 (patent document 3)
Japanese patent application laid-open No. 2013-142061 (patent document 4)
Japanese patent application laid-open No. 2015-174830
Japanese patent application laid-open No. 2000-247851
Japanese patent publication No. 7-29907
Disclosure of Invention
Problems to be solved by the invention
The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a novel oral stain adhesion inhibitor for inhibiting stains from adhering to teeth, and an oral composition containing the inhibitor.
[ means for solving the problems ]
The present inventors have conducted intensive studies in order to achieve the above object, and as a result, found that: the polyacrylate having a weight average molecular weight in a specific range has an intraoral scale removal effect and a scale formation inhibition effect, thereby exhibiting an excellent scale adhesion inhibition effect. It has further been found that when the polyacrylate having a weight average molecular weight in a specific range and a specific chelating agent and/or a specific alginic acid derivative are used in combination, the effect of inhibiting the removal of dirt and/or the formation of dirt in the oral cavity is improved, and the effect of inhibiting the adhesion of dirt is further improved.
It has been found that, in particular, by mixing the above-mentioned combination system into an oral composition, a high scale removal effect and/or a scale formation inhibition effect can be imparted, an excellent scale adhesion inhibition effect can be imparted, and further, a good feel in use and a satisfactory effect feeling (sense of realism of effect) can be imparted, thereby completing the present invention.
Further, the present inventors have found that a polyacrylate having a weight average molecular weight of a specific value or less has an excellent stain removing effect in the oral cavity as a stain firmly fixed to teeth, and further found that the action of the polyacrylate is enhanced and the stain removing effect is remarkably improved when a specific chelating agent is used in combination. Then, it was found that a combination system of the polyacrylate and a specific chelating agent is mixed with the oral composition to provide an excellent stain removing effect, and further to suppress oral irritation in the oral cavity, particularly to mucous membranes, and to provide a feeling of use with a good flavor and taste, thereby completing the first invention.
As a binder for an oral composition, polyacrylic acid or a salt thereof is known, and usually, a crosslinked polyacrylic acid or a salt thereof having a weight average molecular weight of 10 ten thousand or more, usually about 30 ten thousand or more is used. The stains are obtained by forming a colored film on the surface of teeth, which is caused by saliva components, food and drink, and the like, and further laminating, depositing, and firmly constructing the colored film.
In contrast, in the present first invention, it has been found that (a) a polyacrylate having a weight average molecular weight of 1,000 to 20,000, particularly a linear polyacrylate, has: the heretofore unknown effect of removing strong stains already adhering to the tooth surface is achieved, whereby an exceptionally significant effect is obtained which cannot be achieved by polyacrylate having a weight average molecular weight of more than 20,000 or polyacrylic acid having a weight average molecular weight of 20,000 or less but not in the form of a salt.
As shown in comparative example I in tables 1 and 5, which will be described later, the soil removal effect by sodium polyacrylate having a weight average molecular weight of 300,000 or polyacrylic acid having a weight average molecular weight of 6,000 was X, while the soil removal effect by component (a) was O or more, as shown in examples in tables 1 to 5, excellent.
In addition, the removal rate of the scale by the chelating agent was low, and the removal effect was hardly observed (comparative example in table 5 described below). However, as shown in example I in tables 3 to 5, in the first invention, when the specific chelating agent (a) and the specific chelating agent (b) are used together, the synergistic effect between the components is generated, the soil removing effect is remarkably enhanced, and the unpleasant odor caused by the component (a) or the oral cavity irritation and odor caused by the component (b) can be suppressed, and the excellent feeling of use can be maintained.
Further, although the detailed mechanism of action of removing dirt in the first invention is not clear, it is presumed that the component (a) reacts specifically with dirt, and the dirt is easily lifted up, thereby removing dirt. Further, it is presumed that the above-mentioned action is enhanced when the component (b) is further used in combination.
The present inventors have found that, as a second invention, a polyacrylate having a weight average molecular weight of a specific value or less has an effect of inhibiting the formation of scale in the oral cavity, and has an excellent effect of inhibiting the formation of scale, and have further found that, when a specific alginic acid derivative (alginate or alginic acid ester) is used in combination, the effect of the polyacrylate is enhanced and the effect of inhibiting the formation of scale is remarkably improved. Then, it was found that by mixing the above-mentioned polyacrylate and alginic acid derivative in a combination system in an oral composition, an excellent scale formation inhibiting effect can be provided, and further, a satisfactory effect feeling can be provided, and the second invention has been completed.
In the second invention, it is clear that (a) a polyacrylate, particularly a linear polyacrylate, having a weight average molecular weight of 1,000 to 20,000 has: such hitherto unknown action effects of inhibiting the formation of stains on the tooth surfaces in the oral cavity are obtained, and thus, an extremely remarkable action effect which cannot be achieved by polyacrylate having a weight average molecular weight of more than 20,000 or polyacrylic acid having a weight average molecular weight of 20,000 or less but not in the form of a salt is obtained.
As shown in comparative example II in tables 6 and 8, which will be described later, the effect of inhibiting the formation of scale by sodium polyacrylate having a weight average molecular weight of 300,000 or polyacrylic acid having a weight average molecular weight of 6,000 was all x, but as shown in example II in tables 6 and 7, the effect of inhibiting the formation of scale by component (a) was all o or excellent.
As shown in comparative examples in table 8 described below, although the scale formation inhibitory effect by alginate or alginate ester was hardly observed, the scale formation inhibitory effect was remarkably enhanced by the synergistic effect of the component (a) and the component (c) of at least 1 type of alginic acid derivative selected from the group consisting of alginate and alginate ester in the second invention, as shown in examples in tables 6 and 7, and the following effect was felt: after continued use, the tooth surface was perceived to be smooth, and the actual perception was substantially inhibited from scale formation.
Further, the mechanism of action of the inhibition of the formation of stains in the second invention is not clear, but it is presumed that the formation of a colored thin film by binding of saliva components, metal ions from foods and beverages, and the like to the tooth surface is chemically inhibited by the action peculiar to the component (a), and the formation of stains can be inhibited by preventing the accumulation. Further, it is presumed that when component (c) is used in combination, the above effect is remarkably improved, and the adsorption and residue of component (c) on the tooth surface are improved, and the formation of scale can be continuously suppressed even after continuous use, thereby improving the effect feeling.
The invention of patent document 6 is to inhibit staining by coating and to hydrophilize the tooth surface after coating, thereby facilitating removal of a stained film (stained film) and preventing accumulation. The invention of patent document 7 is that the effect can be achieved by using a use amount of about 2.5% or more by suppressing dental calculus by a polyacrylic acid polymer or the like.
In contrast, the present invention is as follows: the effect of the polyacrylate in a non-salt form is poor in the case of the polyacrylate having a specific molecular weight of (a) in the removal of dirt and the inhibition of the formation of dirt, and the adhesion of dirt by these, and on the other hand, the effect is excellent even when the amount of the component (a) in the oral composition is 1 mass% or less.
Accordingly, the present invention provides the following oral cavity soil remover, oral cavity soil formation inhibitor and oral cavity composition.
[ 1 ] an oral cavity soil remover comprising:
(a) A polyacrylate having a weight average molecular weight of 1,000 to 20,000.
[ 2 ] an oral cavity soil remover comprising:
(a) A polyacrylate having a weight average molecular weight of 1,000 to 20,000, and
(b) Chelating agent selected from 1 or more of condensed phosphoric acid, phytic acid (phytic acid), edetic acid (edetic acid), citric acid, malic acid, succinic acid, dicarboxylic acid and their salts with 1 mass% aqueous solution at 25deg.C and pH of 1-11.
The oral cavity soil remover according to [ 2 ], wherein (a)/(b) is 0.01 to 50 in terms of mass ratio.
The oral soil remover according to any of [ 1 ] to [ 3 ], wherein the polyacrylate of component (a) has a weight average molecular weight of 1,000 to 10,000.
[ 5 ] an oral composition comprising:
(a) A polyacrylate having a weight average molecular weight of 1,000 to 20,000, and
(b) Chelating agent selected from 1 or more of condensed phosphoric acid, phytic acid, edetic acid, citric acid, malic acid, succinic acid, dicarboxylic acid and their salts with 1 mass% aqueous solution at 25 ℃ and pH of 1-11.
The composition for oral cavity according to [ 5 ], wherein the polyacrylate of the component (a) has a weight average molecular weight of 1,000 to 10,000.
The composition for oral cavity according to [ 5 ] or [ 6 ], wherein (a)/(b) is 0.01 to 50 in terms of mass ratio.
The composition for oral cavity according to any one of [ 5 ] to [ 7 ], wherein the composition for oral cavity contains 0.01 to 2% by mass of the component (a) and 0.03 to 3% by mass of the component (b).
The composition for oral cavity according to any one of [ 5 ] to [ 8 ], wherein the composition for oral cavity further comprises 0.05 to 2% by mass of (c) 1 or more alginic acid derivatives selected from the group consisting of alginic acid salts and alginic acid esters.
The composition for oral cavity according to any one of [ 5 ] to [ 9 ], which is for removing dirt.
The oral composition according to any one of [ 5 ] to [ 10 ], which is a dentifrice composition.
[ 12 ] an inhibitor of oral cavity scale formation, which comprises (a) a polyacrylate having a weight average molecular weight of 1,000 to 20,000.
[ 13 ] an inhibitor of oral scale formation, comprising:
(a) A polyacrylate having a weight average molecular weight of 1,000 to 20,000, and
(c) More than 1 alginic acid derivative selected from alginate and alginic acid ester.
The inhibitor for oral cavity scale formation according to [ 13 ], wherein (a)/(c) is 0.05 to 5 in terms of mass ratio.
The inhibitor for oral cavity scale formation according to any one of [ 12 ] to [ 14 ], wherein the polyacrylate has a weight average molecular weight of 1,000 to 10,000.
[ 16 ] an oral composition comprising:
(a) A polyacrylate having a weight average molecular weight of 1,000 to 20,000, and
(c) More than 1 alginic acid derivative selected from alginate and alginic acid ester.
The composition for oral cavity according to [ 17 ], wherein the polyacrylate has a weight average molecular weight of 1,000 to 10,000.
The composition for oral cavity according to [ 16 ] or [ 17 ], wherein (a)/(c) is 0.05 to 5 in terms of mass ratio.
The oral composition according to any one of [ 16 ] to [ 18 ], wherein the oral composition contains 0.01 to 2% by mass of the component (a) and 0.05 to 2% by mass of the component (c).
The composition for oral cavity according to any one of [ 16 ] to [ 19 ], which is for inhibiting scale formation.
The oral composition according to any one of [ 16 ] to [ 20 ], which is a dentifrice composition.
[ Effect of the invention ]
The present invention provides an oral soil remover, an oral soil formation inhibitor, and an oral composition containing the same, each having an effect of inhibiting the removal of dirt and/or the formation of dirt in the oral cavity.
That is, according to the present invention, as a first invention, an oral cavity soil remover excellent in the effect of removing oral cavity soil and an oral cavity composition containing the remover can be provided. The composition for oral cavity has high dirt removing effect and good use feeling, and can effectively inhibit dirt, thereby being suitable for whitening in oral cavity and preventing or inhibiting oral diseases.
Further, as the second invention, an oral scale formation inhibitor excellent in the effect of inhibiting the formation of scales in the oral cavity and an oral composition containing the inhibitor can be provided. The composition for oral cavity has high effect of inhibiting the formation of dirt and can give satisfactory effect feeling, so that the composition for oral cavity can effectively inhibit the formation of dirt, and is effective for whitening in oral cavity and preventing or inhibiting oral diseases.
Detailed Description
The present invention will be described in further detail below.
The oral cavity dirt remover and the oral cavity dirt formation inhibitor of the invention comprise the following components: (a) The polyacrylate having a weight average molecular weight of 1,000 to 20,000 is preferably composed of: component (a) and (b) are selected from 1 or more chelating agents selected from 1 or more of condensed phosphoric acid, phytic acid, edetic acid, citric acid, malic acid, succinic acid, dicarboxylic acid and salts thereof having a pH of 1 to 11 at 25 ℃ in a 1 mass% aqueous solution and/or (c) are selected from 1 or more alginic acid derivatives selected from alginate and alginic acid esters.
That is, the oral cavity soil remover of the first invention contains the component (a), preferably contains the components (a) and (b), and the component (a) (preferably the components (a) and (b)) is an effective component for removing the soil. The oral cavity scale formation inhibitor of the second invention contains a component (a), preferably contains a component (a) and a component (c), and the component (a) (preferably the component (a) and the component (c)) is an active component for inhibiting the scale formation. Thus, in the present invention, the component (a) is used; the components (a) and (b), or the components (a), (b) and (c), thereby having a soil removing effect and/or a soil formation inhibiting effect, and exerting an excellent effect of inhibiting the adhesion of the soil by their effect.
In the present invention, the term "dirt adhering" means a state where dirt adheres, and the term "dirt adhering inhibition" means a state where dirt does not adhere. "soil removal" refers to removal of formed fixed soil, and "soil formation inhibition" refers to prevention of fixation of soil.
(a) The polyacrylate of the component (A) has a weight average molecular weight (Mw) of 1,000 to 20,000. In this case, the weight average molecular weight is 1,000 or more, preferably 2,000 or more, and 20,000 or less, preferably 10,000 or less, more preferably 8,000 or less, from the viewpoints of the soil removal effect and the soil formation inhibition effect. When the weight average molecular weight is less than 1,000, the soil removal effect and the soil formation inhibition effect are poor. When the weight average molecular weight is more than 20,000, the soil removal effect and the soil formation inhibition effect are reduced, and sufficient effects cannot be obtained.
The measurement of the weight average molecular weight was performed by GPC (gel permeation chromatography) under the method and measurement conditions described in japanese patent No. 5740859. Specifically, the following is described (the same applies hereinafter).
A method for measuring weight average molecular weight;
the weight average molecular weight is a value measured using a gel permeation chromatograph/multi-angle laser light scattering detector (GPC-MALLS), and the measurement conditions are as follows.
Mobile phase: 0.3M NaClO 4
NaN 3 Aqueous chromatographic column: TSKgel alpha-M2 root
Front column: TSKguardcolumnα
Standard substance: polyethylene glycol
From the viewpoints of the soil removal effect and the soil formation inhibition effect, the polyacrylate of the component (a) is preferably a linear polyacrylate.
The salt is preferably a monovalent salt, more preferably an alkali metal salt or an ammonium salt, further preferably an alkali metal salt such as a sodium salt or a potassium salt, and particularly preferably a sodium salt.
As such polyacrylate, commercially available products sold by Polyscience corporation, toyama Synthesis Co., ltd.
As specific commercial products, sodium polyacrylate (Mw: 1,000) can be used: straight, manufactured by Polyscience corporation; sodium polyacrylate (Mw: 6,000): straight chain, manufactured by Toyama Synthesis Co., ltd., AC-10NP, AC-10NPD, aron T-50; sodium polyacrylate (Mw: 8,000): straight, manufactured by Polyscience corporation; sodium polyacrylate (Mw: 20,000): straight chain, aron A-20UN, manufactured by Toyama Synthesis Co., ltd.
The polyacrylate of the component (a) has a weight average molecular weight lower than that of the polyacrylate of a binder used in a usual dentifrice, and is different from the polyacrylate known as a binder.
When a polyacrylate other than the component (a) or a polyacrylic acid in a form other than a salt is used instead of the component (a), the effect of removing dirt and inhibiting the formation of dirt is poor, and even if the component (b) is further used in combination, the effect is poor, and even if the component (c) is further used in combination, the effect is poor, and the effect feeling is poor, so that the object of the present invention cannot be achieved.
In the present invention, the oral cavity soil remover of the first invention is preferably used in combination with the specific chelating agent (b) in addition to the component (a) as an active ingredient. When the components (a) and (b) are used in combination, the soil removing effect is further improved.
(b) The component (b) is a chelating agent selected from the following (b 1) to (b 5). They may be used alone or in combination of 1 kind or 2 or more kinds. In addition, 2 or more of the components (b 1) to (b 5) may be used in combination.
(b1) The method comprises the following steps More than 1 kind selected from condensed phosphoric acid and its salt with 1 mass% water solution at 25 ℃ and pH of 1-11
(b2) The method comprises the following steps More than 1 selected from phytic acid and its salt
(b3) The method comprises the following steps More than 1 kind selected from edetic acid and its salt
(b4) The method comprises the following steps More than 1 selected from citric acid and its salt
(b5) The method comprises the following steps More than 1 selected from malic acid, succinic acid, dicarboxylic acid and their salts
The types of the salts in (b 1) to (b 5) are not particularly limited, and examples thereof include metal salts such as sodium salts and potassium salts, and sodium salts are particularly preferred.
(b1) The 1% by mass aqueous solution of the condensed phosphoric acid and a salt thereof has a pH of 11 or less, particularly preferably 10 or less at 25 ℃, and the lower limit is not particularly limited, but may be 1 or more and 7 or more.
As the condensed phosphate, sodium salt and potassium salt are preferable.
Specifically, linear or cyclic polyphosphates such as sodium or potassium pyrophosphate, sodium or potassium tripolyphosphate, sodium or potassium tetrapolyphosphate, sodium or potassium metaphosphate, sodium or potassium superphosphate (ultraphosphate sodium or potassium) and the like can be used.
Among them, sodium tripolyphosphate (1% by mass aqueous solution, pH7 to 10 at 25 ℃), sodium pyrophosphate (1% by mass aqueous solution, pH7 to 11 at 25 ℃), sodium metaphosphate (1% by mass aqueous solution, pH1 to 8 at 25 ℃) and sodium superphosphate (1% by mass aqueous solution, pH1 to 7 at 25 ℃) are preferable, and sodium tripolyphosphate is more preferable.
(b2) Particularly preferred are phytic acid and (b 3) particularly preferred are edetate salts, especially preferred are disodium edetate. (b4) Citric acid and sodium citrate are particularly preferable, and citric acid is particularly preferable.
(b5) Is 1 or more than 2 kinds selected from malic acid, succinic acid, dicarboxylic acid and their salts.
Examples of dicarboxylic acids include oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, azelaic acid, sebacic acid, phthalic acid, isophthalic acid, and terephthalic acid.
(b5) Particularly preferred are compounds selected from the group consisting of malic acid, succinic acid and salts thereof. In this case, it is preferable to use a compound containing these compounds.
Further, the ratio of (a)/(b) representing the amount of the component (a) to the component (b) is preferably 0.01 to 50, more preferably 0.01 to 10, particularly preferably 0.01 to 8 in terms of mass ratio. By making this range, the scale removing effect and the feeling of use (oral cavity irritation, smell, taste) are more excellent.
The oral soil remover of the first invention can be obtained by: the component (a) is preferably used alone, and the component (b) is further used in combination, and the above components are mixed. Further, if necessary, a known component for other oral use may be contained, and in this case, a known component may be mixed within a range that does not hinder the effect of the present invention.
In the present invention, in the oral cavity scale formation inhibitor of the second invention, it is preferable that (c) at least 1 kind of alginic acid derivative selected from the group consisting of alginic acid salts and alginic acid esters is used in combination as the active ingredient in addition to the component (a). When the components (a) and (c) are used in combination, the scale formation inhibitory effect is further improved.
(c) The component (a) is a salt or ester of alginic acid as a polysaccharide.
The alginate may be any alginate that is generally used in oral compositions, and sodium alginate may be used. The sodium alginate is preferably sodium alginate having a viscosity of 1 mass% aqueous solution (BL type viscometer, rotor No. 3, 12rpm,20 ℃ C., measurement time of 3 minutes) of 1,000 to 4,000 mPas. For example, a commercially available product such as KIMICA ALGIN from KIMICA corporation may be used.
As the alginic acid ester, any alginic acid ester may be used as long as it is used in a usual oral composition, but propylene glycol alginate is particularly preferable. Among them, an acrylic acid ester having a viscosity of a 1 mass% aqueous solution (BL type viscometer, rotor No. 2, 60rpm,20 ℃ C., measurement time of 3 minutes) of 10 to 200 mPas is preferable. For example, commercially available products such as KIMILOID BF from KIMICA Co., ltd.
Further, the ratio of the amounts of the component (a) and the component (c), (a)/(c), may be 0.005 to 20 in terms of mass ratio, and from the viewpoint of the scale formation inhibitory effect, it is preferably 0.05 to 5, more preferably 0.1 to 2. Within this range, the scale formation suppressing effect and effect feeling are more excellent.
The oral scale formation inhibitor of the second invention can be obtained by: as the active ingredient, the component (a) is used alone, and it is preferable to further mix the above components together with the component (c). Further, if necessary, a known component for other oral use may be contained, and in this case, a known component may be mixed within a range that does not hinder the effect of the present invention.
In the present invention, when the components (a), (b) and (c) are used in combination as the active ingredient, the effect of removing dirt and inhibiting the formation of dirt is improved, the effect of inhibiting the adhesion of dirt is further improved, and a more excellent effect can be provided, and the composition is also suitable as an oral dirt adhesion inhibitor.
The oral composition of the present invention contains a component (a) and a component (b) and/or a component (c).
In the present invention, the first oral composition contains the components (a) and (b), and the second oral composition contains the components (a) and (c). When the oral composition of the present invention contains the components (a), (b) and (c), it is more preferable from the viewpoints of the stain removing effect and the stain formation inhibiting effect.
Specifically, the oral composition may be suitably mixed with a paste, gel or liquid dentifrice (paste dentifrice, gel dentifrice, liquid dentifrice, etc.), mouthwash, oral spray, coating agent, patch, etc. Among these, dentifrice compositions are particularly suitable as paste dentifrice compositions. The first invention is suitable as an oral composition for removing dirt because of its excellent dirt removing effect, and the second invention is suitable as an oral composition for inhibiting dirt formation because of its excellent dirt formation inhibiting effect. The oral composition of the present invention has excellent stain removing effect and stain formation inhibiting effect, and is therefore also suitable as an oral composition for inhibiting the adhesion of stains.
In this case, when the components (a) and (b) are used in combination, the scale removing effect is excellent, and thus (a)/(b) is preferably defined at the above-mentioned specific ratio. The mixing amounts of the component (a) and the component (b) are preferably in the ranges described below, respectively, from the viewpoints of the scale removing effect and the feeling of use, and the above-mentioned components are preferably used in concentrations satisfying these ranges.
When the components (a) and (c) are used in combination, the scale (a)/(c) is preferably the above-mentioned specific ratio gauge because the scale formation inhibitory effect is excellent. The mixing amounts of the component (a) and the component (c) are preferably in the ranges described below, respectively, from the viewpoints of the scale formation inhibitory effect and the effect feeling, and the above-mentioned components are preferably used in concentrations satisfying these ranges.
When the components (a), (b) and (c) are used in combination, the scale removal effect and the scale formation inhibition effect are excellent, and therefore, it is more preferable to define the specific ratios (a)/(b), (a)/(c), respectively. The mixing amounts of the components (a), (b) and (c) are preferably in the ranges described below, respectively, from the viewpoints of the soil removal effect, the soil formation inhibition effect, the feeling of use and the effect feeling, and the above-mentioned components may be used in concentrations satisfying these ranges.
(a) The mixing amount of the components is preferably 0.01 to 2% by mass (the same applies hereinafter) of the whole composition. When the mixing amount is 0.01% or more, a sufficient scale removal effect and scale formation inhibition effect can be obtained. When the mixing amount is 2% or less, the odor derived from the component (a) can be sufficiently suppressed.
Further, when the component (a) and the component (b) are used in combination, the mixing amount of the component (a) is preferably 0.01 to 2%, more preferably 0.03 to 1%, still more preferably 0.03 to 0.8% of the entire composition. When the mixing amount is 0.01% or more, a sufficient scale removal effect can be obtained. When the mixing amount is 2% or less, the odor derived from the component (a) can be sufficiently suppressed.
When the component (a) and the component (c) are used in combination, the mixing amount of the component (a) is preferably 0.01 to 2%, more preferably 0.05 to 1%, still more preferably 0.1 to 0.8% of the entire composition. When the mixing amount is 0.01% or more, a sufficient scale formation inhibiting effect can be obtained. When the mixing amount is 2% or less, a sufficient scale formation inhibiting effect can be obtained, and the odor derived from the component (a) can be sufficiently inhibited.
(b) The mixing amount of the components is preferably 0.03 to 3%, more preferably 0.1 to 3% of the entire composition. When the mixing amount is 0.03% or more, a sufficient scale removal effect can be obtained. When the amount is 3% or less, oral irritation can be suppressed, and a feeling of use with good smell and taste can be imparted.
In addition, in the range of the mixing amount of the component (b), when the component (b 1) is mixed as the component (b), the preferable mixing amount of the component (b 1) is 0.03 to 1%, particularly 0.03 to 0.5% of the whole composition. When the components (b 2) to (b 5) are mixed as the component (b), the preferable mixing amount is 0.03 to 3%, particularly 0.1 to 3% of the whole composition. The components (b 1) to (b 5) may be used in an amount of 1 kind within the above range, or 2 or more kinds may be used in a total amount of the component (b).
(c) The mixing amount of the components is preferably 0.05 to 2%, more preferably 0.1 to 1% of the entire composition. When the mixing amount is 0.05% or more, a sufficient scale formation inhibiting effect can be obtained. When the mixing amount is 2% or less, a sufficient effect feeling can be obtained, and the feeling in use is also good. If the component (c) is more than 2%, the stringiness may be enhanced and the effect may be reduced.
In the oral composition of the present invention, in addition to the above-mentioned component (a), further components (b) and (c), a known component corresponding to a dosage form or the like may be added as an optional component other than these components as required within a range not to impair the effects of the present invention. Specifically, the dentifrice can be produced by blending an abrasive, a binder, a thickener, and a surfactant, and further blending a sweetener, a preservative, a colorant, a flavor, and an active ingredient with water.
Examples of the polishing agent include: silica-based abrasives such as silicic anhydride, crystalline silica, amorphous silica, silica gel (silica gel), and aluminum silicate; calcium phosphate-based abrasives such as tricalcium phosphate, tetracalcium phosphate, anhydrous dicalcium phosphate, dibasic calcium phosphate dihydrate; a zeolite; calcium pyrophosphate; calcium carbonate; sodium bicarbonate; aluminum hydroxide; alumina; magnesium carbonate; tri-magnesium phosphate; zirconium silicate; hydroxyapatite; synthetic resin polishing agent. Among these, from the viewpoints of oral mucosa irritation and usability, silica-based abrasives such as silicic anhydride and calcium phosphate-based abrasives are preferable, and silicic anhydride is particularly preferable.
The mixing amount of the polishing agent is preferably 0 to 60% of the entire composition, and in the case of mixing, 3 to 60% is preferable, and 5 to 55% is particularly preferable. The upper limit is preferably 20% or less, or 15% or less. The amount of abrasive in the paste dentifrice is preferably 10 to 55% of the entire composition, and the amount of abrasive in the mouthwash is preferably 0 to 10% of the entire composition, particularly preferably 0 to 5%.
The oral composition of the present invention has excellent stain-removing effect even without mixing abrasives.
A binder, which may be mixed with gums such as xanthan gum, tragacanth gum, gellan gum, karaya gum, acacia gum and the like; cellulose derivatives such as crosslinked polyacrylate, carrageenan, sodium carboxymethyl cellulose, methylcellulose, hydroxyethyl cellulose, sodium carboxymethyl hydroxyethyl cellulose and the like with a weight average molecular weight of more than 20,000; organic binders such as polyvinyl alcohol, carboxyvinyl polymer, polyvinylpyrrolidone and the like; inorganic binders such as silica gel, alumina silica gel, magnesium aluminum silicate (veegum), and lithium magnesium silicate (laponite) (the mixing amount is usually 0.3 to 10%).
Examples of the thickener include sugar alcohols such as sorbitol, maltitol, lactitol, erythritol and xylitol; the polyhydric alcohol such as propylene glycol may be mixed with 1 or 2 or more (the mixing amount is usually 5 to 70%).
As the surfactant, an anionic surfactant, a nonionic surfactant, and an amphoteric surfactant may be mixed. They may be used in an amount of 1 or 2 or more.
Examples of the anionic surfactant include alkyl sulfates having an alkyl group having 12 to 14 carbon atoms (particularly 12), acyl amino acid salts, acyl taurates, and the like. The acyl groups of the acyl amino acid salt and the acyl taurate are each preferably 12 to 14 carbon atoms, and particularly preferably 12 carbon atoms.
Specifically, as the alkyl sulfate, there may be mentioned: lauryl sulfate, myristyl sulfate; as the acyl amino acid salt, there may be mentioned: acyl glutamate such as lauroyl glutamate, acyl sarcosinate such as myristoyl glutamate, and the like; as acyl taurates, lauroyl methyl taurates are exemplified. The salt is preferably an alkali metal salt such as sodium salt or potassium salt. Alkyl sulphates, acyl sarcosinates and acyl taurates are particularly preferred. Among them, anionic surfactants having a hydrocarbon group (lauryl group) of 12 carbon atoms are preferable, and alkyl sulfate (sodium salt) is more preferable in particular from the viewpoint of being superior to other surfactants in terms of taste.
Examples of the nonionic surfactant include polyoxyethylene alkyl ether, polyoxyethylene-polyoxypropylene block copolymer, polyoxyethylene hydrogenated castor oil, polyoxyethylene ether of glyceride, sucrose fatty acid ester, alkanolamide, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, and glycerin fatty acid ester. Among them, polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, alkanolamide, sorbitan fatty acid ester are suitable from the viewpoint of versatility. The polyoxyethylene alkyl ether has preferably 14 to 30 carbon atoms in the alkyl chain, and preferably 3 to 30 moles of ethylene oxide added on average (average addition of EO). The average addition EO of the polyoxyethylene hydrogenated castor oil is preferably 10 to 100. The number of carbon atoms of the alkyl chain of the alkanolamide is preferably 12 to 14. The fatty acid of the sorbitan fatty acid ester preferably has 12 to 18 carbon atoms; the polyoxyethylene sorbitan fatty acid ester has preferably 16 to 18 carbon atoms in the fatty acid, and preferably 10 to 40 average EO addition.
The amphoteric surfactant includes acylaminoacetic acid betaine having an acyl group having 12 to 14 carbon atoms and fatty acid amidopropyl betaine. Examples of the acylaminoacetic acid betaine include lauroyl dimethylaminoacetic acid betaine and the like; as the fatty acid amidopropyl betaine, coco fatty acid amidopropyl betaine and the like are exemplified.
The mixing amount of the surfactant is preferably 0 to 15%, particularly preferably 0.01 to 10%. The mixing amount of the anionic surfactant is preferably 0.1 to 3%, particularly preferably 0.5 to 2%, and the mixing amount of the nonionic surfactant is preferably 0.01 to 10%.
In the present invention, when a nonionic surfactant, particularly polyoxyethylene hydrogenated castor oil, is used in combination with the component (a), the odor and taste may be deteriorated depending on the amount of the nonionic surfactant added, and when the nonionic surfactant is added together with an anionic surfactant such as an alkyl sulfate, the deterioration of the odor and taste may be prevented, and the scale removal effect and scale formation inhibition effect may be further improved without reducing the feeling of use.
The sweetener may be saccharin sodium, stevioside, dipotassium glycyrrhizinate, perilla herba pepsin (Thaumatin), neohesperidin dihydrochalcone, or aspartyl phenylalanine methyl ester. Examples of the preservative include parahydroxybenzoate and sodium benzoate.
Examples of the colorant include blue No. 1, yellow No. 4, and titanium dioxide.
Fragrances, which may be used: peppermint oil (peppermint oil), spearmint oil, fennel oil, eucalyptus oil, wintergreen oil, cinnamon oil, clove oil, thyme oil, sage oil, lemon oil, orange oil, peppermint oil, cardamom oil, coriander oil, orange oil (mandarin oil), lime oil, lavender oil, rosemary oil, bay oil, chamomile oil, caraway oil, oregano oil (marjoram oil), bay leaf oil, lemon grass oil, oregano oil, pine needle oil, orange flower oil, rose oil, jasmine oil, iris extract, peppermint oil, rose absolute, orange flower absolute and the like, and perfumes obtained by processing (front cut, rear cut, fractional distillation, liquid-liquid extraction, rectification, perfume powdering and the like) of these natural perfumes, and single flavors such as menthol, carvone, anethole, methyl salicylate, cinnamaldehyde, 3-l-menthoxypropane-1, 2-diol, linalool acetate, limonene, menthone, menthyl acetate, N-substituted-p-menthane-3-carboxamide, pinene, octanal, citral, pulegone, carvone acetate, anisyl aldehyde, ethyl acetate, ethyl butyrate, allyl cyclohexyl propionate, methyl anthranilate, ethyl methyl phenyl glycidate, vanillin, undecalactone, hexanal, isoamyl alcohol, hexenol, dimethyl sulfide, methyl cyclopentenone, furfural, trimethyl pyrazine, ethyl lactate, ethyl thioacetate, and further, strawberry flavor, apple flavor, banana flavor, pineapple flavor, grape flavor, mango flavor, pineapple flavor, the known flavor materials used in oral compositions such as butter flavor essence, milk flavor essence, mixed fruit flavor essence, and blended flavors such as tropical fruit flavor essence are not limited to the flavors of examples.
The above-mentioned perfume raw material is preferably used in an amount of 0.000001 to 1% of the entire composition. The flavoring agent using the above-mentioned flavoring material is preferably used in an amount of 0.001 to 2.0% in the composition.
Any active ingredient may be mentioned: nonionic bactericides such as isopropyl methyl phenol; cetylpyridinium chloride (cetylpyridinium chloride) and other cationic bactericides; enzymes such as dextranase (dextranase), mutanase (mutanase), lysozyme (lysozyme), amylase, protease, lysozyme, and SOD (superoxide dismutase); alkali metal monofluorophosphates such as sodium monofluorophosphate and potassium monofluorophosphate; fluoride such as sodium fluoride and stannous fluoride; antiinflammatory agents such as tranexamic acid, epsilon-aminocaproic acid, allantoin aluminum hydroxychloride, dihydrocholesterol, glycyrrhizic acid, glycyrrhetinic acid, etc.; a hyperesthesia improving agent such as potassium nitrate and aluminum lactate; glycerophosphate; chlorophyll; sodium chloride; zinc compounds such as zinc chloride, zinc oxide, and zinc citrate; copper compounds such as gluconic acid ketone and copper sulfate; vitamins such as vitamin A, vitamin B group, vitamin C, and vitamin E; cortex Phellodendri, tea, etc. The number of these active ingredients may be 1 or 2 or more, and an effective amount of these active ingredients may be mixed within a range that does not hinder the effects of the present invention.
The pH (25 ℃) of the oral composition may be in a usual range, and is preferably from 5 to 9, particularly preferably from 6 to 8. In addition, a known pH adjuster may be added to adjust the pH, and hydrochloric acid may be used, for example; or an alkali metal hydroxide such as sodium hydroxide.
Further, preferred embodiments of the first and second inventions are as follows.
[ example ]
The present invention will be specifically described below by way of examples and comparative examples, but the present invention is not limited to the examples described below. In the following examples,% represents% by mass unless otherwise specified.
Further, the weight average molecular weight (Mw) was measured by the same method and measurement conditions as described above using a gel permeation chromatograph/multi-angle laser light scattering detector (GPC-MALLS).
Example I, comparative example I
Oral preparations were prepared in which the polyacrylate salts were mixed in the types and amounts shown in tables 1 to 3 and the component (b) was further mixed, and the scale removal effect was evaluated by the following method. The results are shown in tables 1 to 3.
Dentifrice compositions (paste dentifrices) having the compositions shown in tables 4 and 5 were prepared by a usual method, and filled into aluminum tube containers. Soil removal effect and feel in use were evaluated as follows. The results are shown in tables 4 and 5.
(1) Method for evaluating soil removal effect
A hydroxyapatite plate (manufactured by HOYA corporation, diameter Φ7.0mm×thickness 3.5mm, hereinafter abbreviated as HAP plate) having a surface polished by sand blasting was immersed in each of the following solutions for 30 minutes at room temperature in this order in order as 1 cycle: (i) 0.5% aqueous albumin solution; (ii) Extracting tannin solution (Japanese Tea (brand: laoSong) 50g, black Tea Bag (Brisk Tea Bag, manufactured by Liton Corp.) 5 g with hot water, cooling, adding 12g of coffee powder (manufactured by Nelumbo Corp.) to prepare 1,200mL solution with purified water, repeating the operation of immersing in ammonium solution of 0.56% ferric (III) citrate for 1 cycle for 8-9 times for 1 day until the dirt is sufficiently adhered to HAP plate, and continuing for about 30 days to form firm dirt.
Measurement of L Using a spectrocolorimeter (manufactured by Nippon Denshoku Co., ltd., SE-2000) * The value was used to determine the degree of adhesion of dirt. L of HAP plate before treatment 0 * The value is taken as the initial valuePost-reason L 1 * The value is taken as a blank value. Next, the scale-adhering HAP plate was immersed in artificial saliva (50mM KCl,1mM CaCl) 2 ,0.1mM MgCl 2 ,1mM KH 2 PO 4 Ph 7.0) was diluted 3-fold for 2.5 minutes in the dentifrice solution, and then subjected to a brushing treatment in the same test solution using a plate grinder. 200 times of brushing treatment were performed. Washing with water after brushing, and measuring L 2 * Values. The soil removal rate was calculated according to the following formula, and the soil removal effect was evaluated.
Soil removal rate (%) =
{((L 1 * -L 0 * )-(L 2 * -L 0 * ))/(L 1 * -L 0 * )}×100
Evaluation criteria for soil removal Effect
Very good: the dirt removal rate is above 50%
Very good: the dirt removal rate is more than 40% and less than 50%
Very good: the dirt removal rate is more than 30% and less than 40%
And (3) the following materials: the dirt removal rate is more than 25% and less than 30%
O: the dirt removal rate is more than 20% and less than 25%
Delta: the dirt removal rate is more than 10% and less than 20%
X: the dirt removal rate is less than 10 percent
(2) Method for evaluating sensation of use (oral cavity irritation, smell, taste)
10 panelists placed the dentifrice composition on a toothbrush and brushed their teeth for 3 minutes to clean the oral cavity. The sense of use (oral cavity irritation, smell, taste) at this time was evaluated by sensory evaluation according to the following scoring criteria. The average of scores of 10 persons was calculated, and oral cavity irritation, smell, and taste were determined based on the following evaluation criteria.
Scoring criteria for oral cavity irritation
4, the following steps: no stimulus is felt in the oral cavity
3, the method comprises the following steps: hardly stimulating in the oral cavity
2, the method comprises the following steps: slightly perceived irritation in the oral cavity
1, the method comprises the following steps: intraoral sensory stimulation
Evaluation criteria for oral irritation
And (3) the following materials: average 3.0 to 4.0
O: average 2.5 min or more and less than 3.0 min
Delta: average 1.5 min or more and less than 2.5 min
X: average score is less than 1.5 minutes
Odor scoring criteria
4, the following steps: uncomfortable odors are not perceived in the mouth
3, the method comprises the following steps: hardly perceivable unpleasant smell in the oral cavity
2, the method comprises the following steps: slightly uncomfortable odors were felt in the mouth
1, the method comprises the following steps: uncomfortable odors are perceived in the mouth
Evaluation criteria for odor
And (3) the following materials: average 3.5 to 4.0 minutes
O: average 3.0 min or more and less than 3.5 min
Delta: average score of 2.0 or more and less than 3.0
X: average score less than 2.0
Taste scoring criteria
4, the following steps: no bad smell is felt in the oral cavity
3, the method comprises the following steps: hardly feel peculiar smell in oral cavity
2, the method comprises the following steps: slightly perceived bad smell in the oral cavity
1, the method comprises the following steps: bad smell is felt in the oral cavity
Evaluation criteria for taste
And (3) the following materials: average 3.5 to 4.0 minutes
O: average 3.0 min or more and less than 3.5 min
Delta: average score of 2.0 or more and less than 3.0
X: average score less than 2.0
Details of the raw materials used are as follows.
(a) Sodium polyacrylate (Mw: 1,000)
Straight chain, manufactured by Polyscience Co
(a) Sodium polyacrylate (Mw: 6,000)
Straight chain, manufactured by Toyama Synthesis Co., ltd., AC-10NP
(a) Sodium polyacrylate (Mw: 8,000)
Straight chain, manufactured by Polyscience Co
(a) Sodium polyacrylate (Mw: 20,000)
Straight chain, manufactured by Toyama Synthesis Co., ltd., aron A-20UN
Sodium polyacrylate (Mw: 300,000, comparative composition)
Cross-linking type manufactured by Polyscience Co
Polyacrylic acid (Mw: 6,000, comparative composition)
Straight chain, aron A-10SL manufactured by east Asia Synthesis Co., ltd
(b) Citric acid
Hibiscus chemical industry Co., ltd., product name: refined citric acid (Crystal)
(b) Malic acid (DL-malic acid)
Hibiscus chemical industry Co., ltd., product name: malic acid FUSO
(b) Phytic acid (50% liquid)
Hibiscus chemical industry Co., ltd., product name: phytic acid
(b) Edetic acid disodium salt
Manufactured by pure chemical Co., ltd
(b) Sodium tripolyphosphate
Manufactured by Taiping chemical industry Co Ltd
(b) Sodium metaphosphate
Manufactured by Taiping chemical industry Co Ltd
[ Table 1 ]
[ Table 2 ]
[ Table 3 ]
* : the amount of phytic acid to be mixed was the amount of the pure component (the same applies hereinafter).
[ Table 4 ]
[ Table 5 ]
Example II, comparative example II
An oral preparation containing polyacrylate or alginate in an amount and a type shown in Table 6 was produced by a usual method, and the scale formation inhibitory effect was evaluated in the following manner. The results are shown in Table 6.
Dentifrice compositions (paste dentifrices) having the compositions shown in tables 7 and 8 were prepared by a usual method, and filled into aluminum tube containers. The scale formation inhibitory effect and effect feel were evaluated as follows. The results are shown in tables 7 and 8.
(3) Method for evaluating scale formation inhibition effect
The hydroxyapatite plate (manufactured by HOYA corporation, diameter phi 7.0mm x thickness 3.5mm, hereinafter abbreviated as HA plate) after the surface was polished by sand blasting was measured by a spectrocolorimeter (manufactured by japan electric color corporation, SE-2000) to obtain a Δe value (Δe 0 ). The above HA plate was immersed in (i) a test solution (supernatant obtained by centrifugation of a 3-fold dilution of artificial saliva of an oral preparation), and allowed to stand in a constant temperature bath at 50℃for 10 minutes. Taking out the HA plate and removing the HA plate tableThe water content of the dough was immersed in each of the following solutions at room temperature for 10 minutes in this order, and immersed in a constant temperature bath at 50 ℃): (ii) 0.5% aqueous albumin; (iii) Extracting tannin solution (Japanese Tea (brand: laoSong) 50g, black Tea Bag (Brisk Tea Bag, manufactured by Liton Corp.) 5 g with hot water, cooling, adding 12g of coffee powder (manufactured by Nelumbo Corp.) to obtain 1,200mL solution, mixing with purified water, (iv) 0.56% ferric (III) ammonium citrate aqueous solution, repeating the soaking operation of (i) to (iv) 7 times, drying the HA plate surface, and measuring the ΔE value (ΔE) of the HA plate surface 1 )。
When the same treatment was carried out using purified water instead of the test solution, the respective ΔE values (ΔE before treatment of the fouling preparation solution) were measured in the same manner 0b After the dirt preparation liquid is treated: ΔE 1b ) The scale formation inhibition rate was calculated according to the following formula, and the scale formation inhibition effect was evaluated.
Scale formation inhibition rate (%) =
[(ΔE 1b -ΔE 0b )-(ΔE 1 -ΔE 0 )]/(ΔE 1b -ΔE 0b )×100
Evaluation criteria for inhibitory Effect of Scale formation
Very good: a scale formation inhibition rate of 70% or more
And (3) the following materials: the scale formation inhibition rate is more than 60% and less than 70%
O: a scale formation inhibition rate of 50% or more and less than 60%
Delta: the scale formation inhibition rate is more than 40% and less than 50%
X: the inhibition rate of scale formation is less than 40%
(4) Method for evaluating effect sense
About 1g of the dentifrice composition was put on a toothbrush by 10 subject commentators, and after brushing for 3 minutes over 1 day and 2 times, the feeling of smoothness of the tooth surface was evaluated on 4 scales according to the following evaluation criteria after continuous use for 30 days. The average score of 10 persons was calculated, and the effect feeling (the effect feeling that the tooth surface became smooth) was judged based on the following judgment criteria. An evaluation of o or @, was determined as: the smooth feeling of the tooth surface can be continuously felt, and the effect is good.
Evaluation criteria for Effect feel
4, the following steps: very good feel of
3, the method comprises the following steps: slightly feel to
2, the method comprises the following steps: less feel of
1, the method comprises the following steps: not feel it
Judgment criterion for smooth feeling and continuous feeling
And (3) the following materials: average is more than 3.5 minutes
O: average division into more than 3.0 and less than 3.5
Delta: average division into more than 2.0 and less than 3.0
X: average score less than 2.0
Details of the raw materials used are as follows.
The component (a), sodium polyacrylate (comparative product) and polyacrylic acid (comparative product) used were the same as those described above.
(c) Sodium alginate
KIMICA ALGIN manufactured by Kimica Co., ltd
(c) Propylene glycol alginate
Kimica corporation, kimiloid BF
[ Table 6 ]
[ Table 7 ]
The dentifrices 12 to 19 of example II in table 7 were excellent in the effect of inhibiting the formation of scale and also had a high effect feeling. In addition, the composition has no peculiar smell derived from the component (a), no stringiness and good use feeling.
[ Table 8 ]
The dentifrice compositions (2-1) to (2-13) of example I in table 4 were evaluated for the effect of inhibiting the formation of dirt by the same method as the method (3) described above, and all were excellent.
Claims (13)
1. An oral soil remover comprising:
(a) A polyacrylate having a weight average molecular weight of 2,000 to 8,000, and
(b) 1 or more chelating agents selected from condensed phosphoric acid, phytic acid, edetic acid, citric acid, malic acid and their salts in 1 mass% aqueous solution at 25 ℃ with a pH of 1-11.
2. The oral soil remover according to claim 1, wherein (a)/(b) is 0.01 to 50 in terms of mass ratio.
3. An oral composition comprising:
(a) A polyacrylate having a weight average molecular weight of 2,000 to 8,000, and
(b) 1 or more chelating agents selected from condensed phosphoric acid, phytic acid, edetic acid, citric acid, malic acid, and salts thereof, which are 1 mass% aqueous solutions having a pH of 1 to 11 at 25 ℃.
4. The oral composition according to claim 3, wherein (a)/(b) is 0.01 to 50 in terms of mass ratio.
5. The oral composition according to claim 3 or 4, wherein the oral composition contains 0.01 to 2 mass% of the component (a) and 0.03 to 3 mass% of the component (b).
6. The oral composition according to claim 3 or 4, wherein the oral composition further comprises 0.05 to 2 mass% of (c) 1 or more alginic acid derivatives selected from the group consisting of alginate and alginic acid esters.
7. The oral composition of claim 3 or 4, wherein the oral composition is for soil removal.
8. The oral composition of claim 3 or 4, wherein the oral composition is a dentifrice composition.
9. An oral scale formation inhibitor comprising:
(a) A polyacrylate having a weight average molecular weight of 2,000 to 8,000, and
(c) More than 1 alginic acid derivative selected from alginate and alginic acid ester,
the mass ratio of (a)/(c) is 1 to 5.
10. An oral composition comprising:
(a) A polyacrylate having a weight average molecular weight of 2,000 to 8,000, and
(c) More than 1 alginic acid derivative selected from alginate and alginic acid ester,
the mass ratio of (a)/(c) is 0.05-5.
11. The oral composition according to claim 10, wherein the oral composition contains 0.01 to 2 mass% of the component (a) and 0.05 to 2 mass% of the component (c).
12. The oral composition of claim 10, wherein the oral composition is for inhibiting scale formation.
13. The oral composition of claim 10, wherein the oral composition is a dentifrice composition.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017-230366 | 2017-11-30 | ||
JP2017-230381 | 2017-11-30 | ||
JP2017230366 | 2017-11-30 | ||
JP2017230381 | 2017-11-30 | ||
PCT/JP2018/043498 WO2019107332A1 (en) | 2017-11-30 | 2018-11-27 | Oral stain removing agent, oral stain formation inhibiting agent, and oral composition |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111417381A CN111417381A (en) | 2020-07-14 |
CN111417381B true CN111417381B (en) | 2023-06-30 |
Family
ID=66665038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880076794.6A Active CN111417381B (en) | 2017-11-30 | 2018-11-27 | Oral scale remover, oral scale formation inhibitor, and oral composition |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP7173043B2 (en) |
KR (1) | KR20200093439A (en) |
CN (1) | CN111417381B (en) |
WO (1) | WO2019107332A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020100596A (en) * | 2018-12-25 | 2020-07-02 | ライオン株式会社 | Oral biofilm remover and oral composition |
JP7635508B2 (en) * | 2020-06-26 | 2025-02-26 | ライオン株式会社 | Oral Composition |
WO2022131147A1 (en) * | 2020-12-14 | 2022-06-23 | ライオン株式会社 | Oral cavity composition |
CN114617791B (en) * | 2022-03-07 | 2024-01-16 | 桂林市啄木鸟医疗器械有限公司 | Dental sand blasting powder composition and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000247851A (en) * | 1999-02-26 | 2000-09-12 | Lion Corp | Coating agent for controlling coloration |
JP2006347986A (en) * | 2005-06-17 | 2006-12-28 | Sunstar Inc | Composition for oral cavity |
CN105358128A (en) * | 2013-07-18 | 2016-02-24 | 狮王株式会社 | Elimination agent for oral cavity biofilm and oral cavity composition |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4661341A (en) * | 1984-10-30 | 1987-04-28 | The Procter & Gamble Company | Oral compositions |
JP2606559B2 (en) | 1993-07-15 | 1997-05-07 | 日本電気株式会社 | LSI wiring structure and method of forming the same |
JPH09175968A (en) * | 1995-12-26 | 1997-07-08 | Lion Corp | Composition for oral cavity |
JP3528389B2 (en) | 1995-12-26 | 2004-05-17 | ライオン株式会社 | Oral composition |
JP3803869B2 (en) | 2001-07-05 | 2006-08-02 | サンスター株式会社 | Oral composition |
US6685916B1 (en) * | 2002-10-31 | 2004-02-03 | Cadbury Adams Usa Llc | Compositions for removing stains from dental surfaces, and methods of making and using the same |
JP2008201704A (en) * | 2007-02-20 | 2008-09-04 | Lion Corp | Tooth whitening composition |
US8361942B2 (en) * | 2008-12-09 | 2013-01-29 | The Clorox Company | Hypochlorite denture compositions and methods of use |
JP5705513B2 (en) * | 2010-11-29 | 2015-04-22 | 花王株式会社 | Liquid oral composition |
JP5682264B2 (en) * | 2010-11-30 | 2015-03-11 | ライオン株式会社 | Oral composition and tooth surface adhesion inhibitor for periodontal disease-causing bacteria |
JP5834881B2 (en) * | 2011-12-20 | 2015-12-24 | ライオン株式会社 | Dentifrice composition |
JP5834921B2 (en) | 2012-01-10 | 2015-12-24 | ライオン株式会社 | Dentifrice composition |
JP6307314B2 (en) | 2014-03-13 | 2018-04-04 | アース製薬株式会社 | Oral stain formation inhibitor and oral composition |
KR20180011062A (en) | 2015-05-29 | 2018-01-31 | 라이온 가부시키가이샤 | Composition for use in oral cavity |
WO2018194111A1 (en) * | 2017-04-21 | 2018-10-25 | ライオン株式会社 | Oral biofilm removing agent and oral composition |
-
2018
- 2018-11-27 CN CN201880076794.6A patent/CN111417381B/en active Active
- 2018-11-27 JP JP2019557223A patent/JP7173043B2/en active Active
- 2018-11-27 KR KR1020197038562A patent/KR20200093439A/en not_active Withdrawn
- 2018-11-27 WO PCT/JP2018/043498 patent/WO2019107332A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000247851A (en) * | 1999-02-26 | 2000-09-12 | Lion Corp | Coating agent for controlling coloration |
JP2006347986A (en) * | 2005-06-17 | 2006-12-28 | Sunstar Inc | Composition for oral cavity |
CN105358128A (en) * | 2013-07-18 | 2016-02-24 | 狮王株式会社 | Elimination agent for oral cavity biofilm and oral cavity composition |
Non-Patent Citations (1)
Title |
---|
海藻酸作为活性药物和新型药用敷料的开发;李红兵;《海洋技术》;20060630;第25卷(第2期);第59-62页 * |
Also Published As
Publication number | Publication date |
---|---|
WO2019107332A1 (en) | 2019-06-06 |
JP7173043B2 (en) | 2022-11-16 |
CN111417381A (en) | 2020-07-14 |
KR20200093439A (en) | 2020-08-05 |
JPWO2019107332A1 (en) | 2020-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111417381B (en) | Oral scale remover, oral scale formation inhibitor, and oral composition | |
KR102146681B1 (en) | Elimination agent for oral cavity biofilm and oral cavity composition | |
JP6471667B2 (en) | Liquid oral composition | |
CN106999363B (en) | Oral composition | |
CN111356440A (en) | Oral biofilm formation inhibitor and oral composition | |
WO2013080762A1 (en) | Dentifrice composition | |
HK1248103A1 (en) | Composition for oral cavity and food product, or beverage | |
EP3071299B1 (en) | Tooth varnish compositions and methods for their use | |
CN103974689B (en) | Dentrifice composition and the Recalcification promoter of tooth | |
JP5488096B2 (en) | Oral composition | |
WO2016121650A1 (en) | Dentifrice composition | |
CN107613948B (en) | Oral composition | |
JP2015117215A (en) | Dentifrice composition | |
JP2009107988A (en) | Dentifrice composition | |
JP2021095380A (en) | Dentifrice composition | |
JP5948903B2 (en) | Dentifrice composition and method for improving antiseptic power of dentifrice composition | |
JP4892949B2 (en) | Dentifrice composition | |
CN108463208B (en) | Oral care compositions | |
JP2013142061A (en) | Dentifrice composition | |
JP2006096696A (en) | Composition for oral cavity | |
JP2005041787A (en) | Dentifrice composition | |
JP2009107989A (en) | Toothpaste composition, and method for suppressing liquid segregation of the same | |
JP2016141661A (en) | Oral composition | |
CN107249547B (en) | Dentifrice composition | |
WO2019107340A1 (en) | Composition for oral use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |